China Cancer (ISSN 1004-0242, CN 11-2859/R) (monthly) was founded in 1986 and was officially published in 1992. It is supervised by the National Health Commission, and sponsored by the Chinese Academy of Medical Sciences and the National Cancer Research and Control Office, PRC. The purpose of the journal is to exchange tumor prevention and treatment experience, promote tumor scientific and technological achievements, and promote the development of tumor prevention and treatment. China Cancer has been rated as a high-quality scientific and technological journal in China for many years. It’s also been selected into Chinese core journals, Chinese Science Citation Database, the key magazine of China technology, and indexed in World Journal Clout Index (WJCI) Report (2021). The main columns include cancer monitoring, prevention and treatment, hospital management, research progress. China Cancer features in providing the influential and state-of-art findings of cancer prevention and epidemiology and it is an important forum for oncology community to communicate the experience of cancer prevention and treatment.

Journal of Chinese Oncology (ISSN 1671-170X, CN 33-1266/R) (monthly) is a flagship journal of China Anti-Cancer Association which has been selected into the key magazine of China technology and won the award of excellent journal in East China. Journal of Chinese Oncology was founded in 1971, officially published in 1995, and change to the present name in 2001. It is charged by Health Commission of Zhejiang Province, and jointly sponsored by Zhejiang Cancer Hospital/the Cancer Hospital of the University of Chinese Academy of Sciences and Zhejiang Anti-Cancer Association. Journal of Chinese Oncology has always implemented the purpose of providing authoritative guidance to specialists in clinic, research and teaching of oncology and reporting new technologies, new achievements and new progress in the field of oncology research. Journal of Chinese Oncology welcomes all sorts of articles including special report, basic and clinical research, review, communication, case report, and focuses on research about diagnosis and treatment of common malignant tumors, which provides an important platform to exchange new findings for tumor oncology specialists, clinicians and researchers.